State Street SPDR S&P Biotech ETF (XBI) News
Track canonical SquawkNews coverage tagged to XBI, State Street SPDR S&P Biotech ETF. This hub brings together deduplicated headlines about alpaca us equities, markets catalysts, earnings, analyst actions, and wider market events so traders can review how a developing story changed over time. It contains 10 indexed stories across 6 publication days and is ordered by the same first-publication timeline used by LiveCast.
H
Biotech ETF XBI Hits an Interest Rate Wall as 40+ Catalysts Approach
The biotech sector is heading into the third-quarter earnings season with a tug-of-war between higher interest rates and an unusually heavy pipeline of company-specific catalysts. The SPDR S&P Biotech ETF (NYSE: XBI ) is
LIVE | Sep 25, 2026, 08:19 PM UTC
H
Economy Grows 63% in Six Years, 30-Year Treasury Lost Almost As Much
The U.S. economy has grown faster in dollar terms over the past six years than at almost any point in modern memory. Over the same stretch, the bond meant to be the world’s safest long-term asset has lost more than half
LIVE | Sep 25, 2026, 06:00 PM UTC
L
RBC says AI weakness appears to be fueling biotech rally
RBC SAYS AI WEAKNESS APPEARS TO BE FUELING BIOTECH RALLYWeakness in artificial intelligence-related stocks may be helping fuel a biotech rally as investors shift money from volatile technology shares into healthcare stoc
EQUITY | Sep 23, 2026, 01:15 PM UTC
H
Novavax rises as biotech rally spreads after Merck-Moderna data
Novavax shares are trading higher Wednesday as a broad biotech rally follows Merck and Moderna Phase 3 INTerpath-001 melanoma results; no Novavax-specific catalyst was supplied.
EQUITY | Aug 19, 2026, 04:33 PM UTC
M
XBI: Trump nominates Heidi Overton as next FDA commissioner
Hammerstone MarketTalk reports that Trump nominates Heidi Overton, MD, PhD, as the next FDA commissioner, impacting the FDA leadership transition relevant to regulated healthcare and biotech.
REGULATION | Aug 19, 2026, 04:13 PM UTC
L
XBI Biotech jumps to all-time highs, up 3.15% to $165.53
XBI Biotech trades at all-time highs, rising 3.15% to $165.53.
EQUITY | Aug 19, 2026, 01:35 PM UTC
L
XBI Biotech hits all-time high, up 3.15%
XBI Biotech reaches an all-time high and is up 3.15% to 4165.53, with no catalyst supplied in the alert.
EQUITY | Aug 19, 2026, 01:35 PM UTC
L
XBI +1.5% around $154 level, as Biotech a Bright spot today (down from recent record highs $165.71)
XBI +1.5% around $154 level, as Biotech a Bright spot today (down from recent record highs $165.71)
EQUITY | Jul 17, 2026, 07:43 PM UTC
L
XBI IBB Prediction market giant Kalshi announced this morning that it will now start taking bets on clinical trial outcomes and FDA approval
XBI IBB Prediction market giant Kalshi announced this morning that it will now start taking bets on clinical trial outcomes and FDA approvals, STAT News reported. It’s starting with a small number of markets selected alo
REGULATION | Jul 16, 2026, 12:12 PM UTC
L
XBI ETF near highs
XBI ETF is trading near its highs
EQUITY | Jun 25, 2026, 02:59 PM UTC